The application of in silico experimental model in the assessment of ciprofloxacin and levofloxacin interaction with main SARS-CoV-2 targets: S-, E- and TMPRSS2 proteins, RNA-dependent RNA polymerase and papain-like protease (PLpro)—preliminary molecular docking analysis

BACKGROUND: The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified at the end of 2019. Despite growing understanding of SARS-CoV-2 in virology as well as many molecular studies, except remdesivir, no specific anti-SARS-CoV-2 drug has been officially approved. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Marciniec, Krzysztof, Beberok, Artur, Boryczka, Stanisław, Wrześniok, Dorota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164684/
https://www.ncbi.nlm.nih.gov/pubmed/34052981
http://dx.doi.org/10.1007/s43440-021-00282-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164684/
https://www.ncbi.nlm.nih.gov/pubmed/34052981
http://dx.doi.org/10.1007/s43440-021-00282-8

Ejemplares similares